Proper assessment of heated tobacco products (HTPs), which are alternatives to cigarettes that heat rather than burn tobacco, is necessary to gain a full understanding of both the potential risks and benefits of these newer products. This includes understanding differences in HTP aerosol compared to cigarette smoke. Recent publications have attempted to characterize HTP emissions in order to provide guidance on relative risk and classification. However, improper representation of studies and misinterpretation of how products are designed and used has led to confusion about the relative risk of HTPs compared to cigarettes. This commentary provides clarification on these important issues with a focus on classification of emissions from the device.
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.